STAAR Surgical rises on Q1 beat; Wedbush upgrades on China recovery
Source: SeekingAlpha
2026-05-14 09:58:25 ET
More on STAAR Surgical
- STAAR Surgical Company (STAA) Q1 2026 Earnings Call Transcript
- STAAR Surgical: Q1 Preliminary Revenues Justify Decision To Reject Alcon Bid
- STAAR Surgical: Despite Promises Of Improvement, Investors Should Stay Cautious
- STAAR targets about 75% gross margin and $225M 2026 spend as Switzerland plans to supply 100% of China lenses
- STAAR Surgical Non-GAAP EPS of $0.48 beats by $0.40, revenue of $93.5M beats by $14.78M
Read the full article on Seeking Alpha
For further details see:
STAAR Surgical rises on Q1 beat; Wedbush upgrades on China recovery
STAAR Surgical Company
NASDAQ: STAA
STAA Trading
13.28% G/L:
$32.85 Last:
2,261,879 Volume:
$35.77 Open:
STAA Latest News
May 13, 2026 04:01:00 pm
STAAR Surgical Reports First Quarter 2026 Results; Issues Shareholder Letter
May 04, 2026 04:01:00 pm
STAAR Surgical to Host First Quarter 2026 Earnings Results Call and Webcast on May 13, 2026
STAA Stock Data
$865,509,982
49,244,533
31.2%
72
N/A
Medical Equipment & Supplies
Healthcare
US
Lake Forest
